Keywords: roche, acquires, thp, million, switzerland, number, drugmaker

Roche acquires THP for $56.5 million

Article | 09 April 2007

Switzerland's number two drugmaker, Roche, has acquired Therapeutic Human Polyclonals, a privately-held biotechnology firm based in California, USA, and Germany, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing